Lymphotoxin beta receptor agents in combination with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01)

Patent

CA 2509495

This invention features combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other chemotherapeutic agents, as well as therapeutic methods and screening methods for identifying agents that in combination with a lymphotoxin-beta receptor agonist agent have a supra-additive effect on tumor inhibition.

L'invention concerne des thérapies de combinaison comprenant une composition activant la signalisation de récepteur bêta de la lymphotoxine en combinaison avec un ou plusieurs agents chimiothérapeutiques, ainsi que des méthodes thérapeutiques et des méthodes de criblage permettant d'identifier les agents qui présentent, en combinaison avec un agent agoniste des récepteurs bêta de la lymphotoxine, un effet supra-additif sur l'inhibition des tumeurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lymphotoxin beta receptor agents in combination with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lymphotoxin beta receptor agents in combination with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphotoxin beta receptor agents in combination with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1782323

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.